Supplement 4: Canadian Guidelines on Parkinson's Disease
- 1 July 2012
- journal article
- practice guideline
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences
- Vol. 39 (S4), S1-S30
- https://doi.org/10.1017/s031716710001516x
Abstract
No abstract availableThis publication has 61 references indexed in Scilit:
- Treatment of insomnia in Parkinson's disease: A controlled trial of eszopiclone and placeboMovement Disorders, 2010
- Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson diseaseNeurology, 2010
- A controlled trial of antidepressants in patients with Parkinson disease and depressionNeurology, 2009
- Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson DiseaseA Randomized Controlled TrialJAMA, 2009
- A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Treatment of sialorrhoea in patients with Parkinson??s disease: best current evidenceCurrent Opinion in Neurology, 2007
- The impact of depressive symptoms in early Parkinson diseaseNeurology, 2007
- Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's diseaseMovement Disorders, 2007
- Orthostatic hypotension as an early finding in Parkinson’s diseaseClinical Autonomic Research, 2006
- Symptoms of autonomic failure in Parkinson?s disease: prevalence and impact on daily lifeClinical Autonomic Research, 2005